Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 1824005 approvals

NKGen Biotech Korea Co., Ltd.

Official website

NKGen Biotech Korea licenses out NK cell therapy patents to NKGen Biotech Inc. and provides immune diagnostic and healthcare products.

As of 2026-10-10, NKGen Biotech Korea Co., Ltd. has 5 Korean MFDS device approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2002, NKGen Biotech Korea listed on KOSDAQ in 2015 as an immune diagnostics and immunotherapy healthcare company; it entered court receivership in June 2024 and completed the process in September 2025 with NKGen Biotech, Inc. as the designated acquirer, subsequently adopting its current name. It offers research reagents, the NK Vue® diagnostic kit, and SuperNK, along with various immune-based healthcare products and services including health functional foods for immune management. It has licensed out its patent for an EPB41L5 protein-specific epitope-recognizing antibody to Cellasta Co. (formerly Repurpose Us) for a total of KRW 20 billion, and NK cell therapy patent-related technology to NKGen Biotech, Inc. (formerly NKMAX America) for a total of USD 11 million.

Products & technology

  • Research reagents
  • NK Vue® KITNK cell activity diagnostic kit
  • SuperNKNK cell therapy

Regulatory approvals

data.go.kr

5 Korean MFDS device approvals · 2012–2016

  • MFDSIVD reagents for general immune test2016-10-18
    Product approval · Class 2체외 제인 16-759 호
  • MFDSTube, blood collecting, sealed, evacuated2015-02-16
    Product approval · Class 1경인 제신 15-75 호
  • MFDSTube, blood collecting, sealed, evacuatedRevoked2014-09-02
    Product approval · Class 1경인 제신 14-510 호
  • MFDSIVD reagents for general immune test2012-10-23
    Product approval · Class 2체외 제허 12-1357 호
  • MFDSTube, blood collecting, sealed, evacuatedRevoked2012-09-17
    Product approval · Class 1경인 제신 12-309 호

Global clinical trials

ClinicalTrials.gov · sponsor-matched

Key disclosures

KRX KIND via OpenDART
Show 30 more events

Patents

KIPRIS · applicant-matched
Show 14 more patents

AI reads

MAA server logs · IP-verified
76
Times AI engines pulled NKGen Biotech Korea Co., Ltd.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

76
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

11
live 0
Last 7 days
65
live 0
Last 30 days
76
live 0
All time
  • OpenAIOAI-SearchBot67
  • GoogleGoogleOther3
  • PerplexityPerplexityBot3
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 8, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for NKGen Biotech Korea Co., Ltd. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

GC Medical Science Corporation2 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

SD BIOSENSOR INC.2 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

NanoenTek,Inc.1 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

Hanmi Science Co.,Ltd1 shared

KOSPI-listed operating holding company of the Hanmi Pharm group, also running healthcare and pharmaceutical wholesale businesses.

Eone Diagnomics Genome Center Co., Ltd.1 shared

EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.

HUMASIS CO., LTD.1 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

RollingStone Co., Ltd.1 shared

KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.

Access Bio, Inc.1 shared

Founded in 2002 and KOSDAQ-listed in 2013, Access Bio develops rapid diagnostic tests for malaria, COVID-19, and other infectious diseases.

PeopleBio, Inc.1 shared

KOSDAQ-listed IVD company selling AlzOn and AlzOn+ blood-based oligomeric beta-amyloid tests for Alzheimer's risk assessment.

GENEMATRIX INC.1 shared

KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.

QuantaMatrix Incorporated1 shared

Established in 2010, listed on KOSDAQ in 2020, QuantaMatrix develops dRAST and QDST antimicrobial susceptibility testing systems.

Genesystem Co., Ltd1 shared

Founded 2010, listed on KOSDAQ in 2021, Genesystem develops molecular diagnostic systems, biochips, test kits, and reaction reagents.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition